Elizabeth Rutherford
Obstetrics & Gynecology · Valparaiso, INNPI 1083653711
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 44.0% of the total. Reporting peaked in 2022 at $823 and has fallen 98.1% since, to $16 in 2025.
Across 132 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Hologic Sales And Service, LLC$231
- Coopersurgical, Inc.$147
- Astellas Pharma US Inc$119
- Therapeuticsmd, Inc.$115
- AMAG Pharmaceuticals, Inc.$81
- plus $651 from 18 others
What the payments were for
- Food & beverage$2,31797%
- Education$813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 67 | $1,055 |
| Hologic Sales And Service, LLC | 5 | $231 |
| Coopersurgical, Inc. | 4 | $147 |
| Astellas Pharma US Inc | 6 | $119 |
| Therapeuticsmd, Inc. | 7 | $115 |
| AMAG Pharmaceuticals, Inc. | 5 | $81 |
| Avion Pharmaceuticals | 4 | $73 |
| Pfizer | 4 | $66 |
| Agile Therapeutics, Inc. | 3 | $66 |
| Merck | 4 | $62 |
| Mayne Pharma Commercial LLC | 3 | $53 |
| Myovant Sciences Inc. | 4 | $52 |
| Exeltis, USA Inc. | 3 | $44 |
| Novo Nordisk | 1 | $40 |
| Lupin Inc. | 3 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Organogenesis Inc. | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Medicem Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Hologic Inc | 1 | $14 |
| Dysis Medical, Inc. | 1 | $12 |
| Aspira Women's Health Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACESSA PROVU SYSTEM$140
- Endosee$105
How this compares
$2,398 in reported general payments places this provider in the 80th percentile of 743 obstetrics & gynecology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $1,715 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Valparaiso
- Jeannette Colon-MarinValparaiso$13K
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
- Enrique InfanteElkhart$41K
- Paul MorrisonNewburgh$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.